A    B    C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z    
Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Ripretinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Ripretinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Ripretinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.

Ripretinib Related Compounds

Stable Isotopes

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
N-Desmethyl-Ripretinib 13C6 Stable Isotopes CS-O-53143 1442473-09-7 (Unlabelled) Enquire
Ripretinib D5 Stable Isotopes CS-O-42914 1442472-39-0 (Unlabelled) Enquire


API Standards

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
Ripretinib API Standards CS-ZB-22559 1442472-39-0 Enquire


Metabolites

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
N-desmethyl Ripretinib Metabolites CS-O-46221 1442473-09-7 Enquire


Impurities

COMPOUND CATEGORY CAT. No. CAS. No. STOCK STATUS
N-Nitroso Ripretinib Impurities CS-EO-02710 Not Available Enquire